Skip to main content
. 2019 Jan 29;14(1):e0211268. doi: 10.1371/journal.pone.0211268

Table 3. CI values for the investigated combinations in PANC-1 cells.

Compound combination Combination ratio CI valuesa at effect level of CIwt valuesb Assigned symbolc
75% 90%
cisplatin + beta-escin 1 : 1.247 1.007
(1.015 +/- 0.239)
0.826
(0.845 +/- 0.320)
0.868 +
cisplatin + camptothecine 1 : 0.083 0.345
(0.341 +/- 0.069)
0.245
(0.242 +/- 0.071)
0.376 +++
cisplatin + daunorubicin 1 : 0.022 0.680
(0.670 +/- 0.147)
0.449
(0.453 +/- 0.149)
0.552 +++
cisplatin + hycanthone 1 : 0.250 0.837
(0.836 +/- 0.139)
0.614
(0.616 +/- 0.150)
0.665 +++
cisplatin + topotecan 1 : 0.250 0.395
(0.392 +/- 0.070) 
0.277
(0.275 +/- 0.075)
0.340 +++
cisplatin + vorinostat 1 : 0.749 0.495
(0.492 +/- 0.074)
0.305
(0.303 +/- 0.068)
0.361 +++
carboplatin + aminacrine 1 : 0.034 0.380
(0.389 +/- 0.097)
0.265
(0.276 +/- 0.109)
0.302 +++
carboplatin + daunorubicin 1 : 0.010 0.974
(0.976 +/- 0.182) 
0.630
(0.638 +/- 0.220)
0.727 ++
carboplatin + hycanthone 1 : 0.101 0.524
(0.528 +/- 0.054)
0.408
(0.414 +/- 0.068)
0.351 +++
carboplatin + topotecan 1 : 0.084 0.095
(0.097 +/- 0.023)
0.018
(0.019 +/- 0.008)
0.077 +++++
oxaliplatin + topotecan 1 : 1.265 0.819
(0.836 +/- 0.241)
0.824
(0.899 +/- 0.769)
0.827 ++

a CI values were calculated using CompuSyn [62]; the values in brackets represent the means ± 95% confidence intervals, as determined from the sequential deletion analysis (S.D.A.) as a measure of the CI variability at the presented effect levels (i.e., at IC75 and IC90).

b Weighted average CI values, calculated as follow: CIwt = (CI50 + 2CI75 + 3CI90 + 4CI95)/10.

c Degrees of synergism (+ signs) or antagonism (- signs) are based on the ranges of CIwt values as described in ref. [31]; (±) near additive effect, (+) slight synergism, (++) moderate synergism, (+++) synergism, (++++) strong synergism and (+++++) very strong synergism; antagonism is divided in the same way, except using “-”signs.